News & Updates

Electrofulguration effective against recurrent UTI in menopausal women
Electrofulguration effective against recurrent UTI in menopausal women
25 Sep 2023

Treatment with electrofulguration for antibiotic-refractory recurrent urinary tract infections (UTI) demonstrates durable clinical cure and improvement over 5 years in menopausal women, reducing the need for long-term antibiotics, a study has shown.

Electrofulguration effective against recurrent UTI in menopausal women
25 Sep 2023
Inadequate sleep tied to higher incidence of urgent urinary incontinence
Inadequate sleep tied to higher incidence of urgent urinary incontinence
09 Sep 2023

Urgent urinary incontinence appears to occur more frequently among people with insufficient sleep than among those with moderate sleep duration, according to a study.

Inadequate sleep tied to higher incidence of urgent urinary incontinence
09 Sep 2023
Working out heightens sexual function in men with prostate cancer
Working out heightens sexual function in men with prostate cancer
29 Aug 2023 byJairia Dela Cruz

Prostate cancer treatment upends sexual function in men, but the good news is that supervised resistance and aerobic workout can counter these sexual side effects, according to a study presented at ASCO Breakthrough 2023.

Working out heightens sexual function in men with prostate cancer
29 Aug 2023
Female stress urinary incontinence affects male partners’ sexual function
Female stress urinary incontinence affects male partners’ sexual function
29 Aug 2023 byStephen Padilla

Stress urinary incontinence (SUI) in women appears to have a significant impact on their partners’ sexual function, suggests a study. Furthermore, female anti-incontinence surgery does not seem to improve the sexual function of their partners.

Female stress urinary incontinence affects male partners’ sexual function
29 Aug 2023
Real-world data: High rates of complications and unplanned hospital admissions in mHSPC
Real-world data: High rates of complications and unplanned hospital admissions in mHSPC
15 Aug 2023 byChristina Lau

Seventy percent of patients with metastatic hormone-sensitive prostate cancer (mHSPC) experience disease-related complications, while 59 percent require ≥1 unplanned hospital admission during the course of disease, a study by the Chinese University of Hong Kong (CUHK) has shown.

Real-world data: High rates of complications and unplanned hospital admissions in mHSPC
15 Aug 2023